Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Organoids × ixabepilone × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 46 Neoplasms 9 Prostatic Neoplasms 7 Neoplasm Metastasis 6 Unspecified Adult Solid Tumor, Protocol Specific 5 Carcinoma, Ovarian Epithelial 5 Breast Neoplasms, Male 5 Sarcoma 4 Ovarian Neoplasms 4 Pancreatic Neoplasms 3 Lung Neoplasms 3 Kidney Neoplasms 3 Endometrial Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Non-Small-Cell Lung 3 Wilms Tumor 2 Testicular Neoplasms 2 Teratoma 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Salivary Gland Neoplasms 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Anaplastic 2

Interventions

pyrrolidine 1 pirarubicin 1 olaparib 1 ixabepilone 1 exemestane 1 eribulin 1 apatinib 1 Vinorelbine 1 Trastuzumab 1 Toremifene 1 Tamoxifen 1 Paclitaxel 1 Methotrexate 1 Letrozole 1 Gemcitabine 1 Fulvestrant 1 Fluorouracil 1 Epirubicin 1 Endostatins 1 Doxorubicin 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Capecitabine 1 Bevacizumab 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03925233 2019-04-24

Breast Cancer Treatment Based on Organ-like Culture

Xijing Hospital

Breast Cancer Organoids

Data powered by HemOnc (CC BY 4.0) Colophon ⚡